Innovative New Pharma and Biotech Partnerships: How is the Landscape Transforming?
The global pharmaceutical market will be worth more than $1.5 trillion by 2023. This represents an annual growth of 3%−6% over the next five years and an attractive area for big investment. Challenged with developing the next generation of therapies from purely internal R&D, global pharmaceutical and biotech companies are increasingly looking to form innovative new partnerships to drive portfolio value and growth.
A panel of experts from industry, CROs, medical charities and VCs will share some of their experiences and lessons learned on how these institutions have developed strategies to deal with this evolving landscapes.
Our Head of Virtual R&D, Dr Graeme Wilkinson, will be presenting at the event on ‘the challenges and opportunities of collaborating in a not-for-profit organisation’.
